Skip to main content
. Author manuscript; available in PMC: 2024 Apr 1.
Published in final edited form as: Dis Colon Rectum. 2022 Jun 20;66(4):549–558. doi: 10.1097/DCR.0000000000002452

Table 2.

Patient and family history in relation to the etiology of MMR-D.

History No. of patients (%)
P value Pairwise P values
HM-MSI (n = 103) LS-MSI (n = 28) DS-MSI (n = 17)

Met diagnostic criteria
 Revised Bethesda 40 (39) 26 (93) 13 (77) <0.001 <0.0001,a 0.007,b 0.179c
 Amsterdam III 0 10 (36) 0 <0.001 <0.0001,a 0.007c
Personal history
 Metachronous CRC 4 (4) 8 (29) 0 <0.001 0.0005,a 1.000,b 0.017c
 Synchronous CRC 3 (3) 1 (4) 0 0.752
 LS-related neoplasmsd 4 (4) 3 (11) 0 0.199
Family history
 CRC 37 (36) 22 (79) 5 (29) <0.001 <0.0001,a 0.785,b 0.002c
 LS-related neoplasmsd 22 (21) 14 (50) 5 (29) 0.012 0.004,a 0.532,b 0.222c

Abbreviations: CRC, colorectal cancer; DS, double somatic; HM, hypermethylation; MMR-D, mismatch repair deficient; LS, Lynch syndrome; MSI-H, microsatellite instability-high.

a

HM-MSI vs LS-MSI

b

HM-MSI vs DS-MSI

c

LS-MSI vs DS-MSI

d

Noncolorectal